Navigation Links
Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey

MALVERN, Pa., March 6, 2013 /PRNewswire/ -- Michael Hickey, former Vice President of US Sales at AstraZeneca and former President of AstraZeneca, Netherlands has recently joined Delta Point , Inc. as Senior Vice President of Global Leadership Development. "Michael is a perfect fit for the future direction of Delta Point as we focus on the sales leadership required for the delivery of exceptional sales performance," explained Jerry Acuff , founder and CEO of Delta Point. "Developing the expertise of the sales leaders and especially sales managers translates to increased bottom line results for our customers."

Michael Hickey graduated from University College Dublin with a degree in Pharmacy, an MSc in Pharmaceutical Chemistry and an MBA.  He also completed residential advanced management programs in strategic marketing in Harvard University and the AMP in INSEAD, France. 

Michael Hickey has a deep understanding of the pharmaceutical business having worked in the industry for 30 years in many and varied functions such as production, clinical research, marketing, sales and senior management in the US, Canada and a number of European countries. 

During his time as VP Sales in the US, he successfully led the successful launch of megabrands such as Crestor, Seroquel and Nexium and also a number of oncology brands.  His innovative and creative approach led to the introduction of a new AZ selling model in the US and also in the Netherlands and to the introduction of a comprehensive SFE (Sales Force Effectiveness) program in the US which was later adopted worldwide.   Following his time with AZ, Michael became President of IBA Molecular, North America, a leading radiopharmaceutical company. 

About Delta Point , Inc.

Headquartered in Scottsdale, AZ with a regional office in Malvern, PA, Delta Point , Inc. specializes in the life sciences industry (pharmaceutical, biotech, and device companies) by partnering with clients to maximize brand sales performance. Their focus is on improving outcomes by analyzing the needs of their customers before developing customized recommendations that align cross-functional departments: Sales, Marketing, Sales Training and Commercial Operations. Delta Point specializes in making those changes that help corporations deal with the challenges they face whether it is launching a new product or an underperforming brand by working with Marketing, Sales Management, Sales Training and Sales Operations as a partner in attaining business success. They have gained recognition for developing strategic sales and marketing plans, improving sales messaging, and for the effectiveness of their training programs, including a copyrighted process of building, sustaining and growing substantive business relationships.

Jerry Acuff , CEO
Delta Point , Inc.

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Delta Point , Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Adam Chasse Inducted Into Delta Omega Public Health Honorary Society
2. Downsizing and the Need for Increased Selling Effectiveness Fuel Delta Points Growth
3. Quadrant Engineering Plastic Products Appoints a New England Territorial Manager and Production Supervisor
4. Creabilis Appoints Catherine Moukheibir to its Board of Directors
5. Janet Kreizman Appointed Chief Executive Officer of AACC
6. Verenium Appoints Holger Liepmann To Its Board Of Directors
7. Ancient Egyptian blue pigment points to new telecommunications, security ink technology
8. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England
9. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
10. Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
11. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
Post Your Comments:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):